TP53 and B-cell chronic lymphocytic leukemia: To confirm these results in a mouse model of aggressive CLL with dysfunctional p53 [9], we transplanted the human CLL cell line MEC-1 in Rag2−/−γc−/− mice, a model that is insensitive to fludarabine treatment.